Skip to main content
B

BioLab

BioLab develops and manufactures clinically focused wound care products, including a fully synthetic antimicrobial matrix and biologically derived amniotic membrane wraps, to protect against infection and promote tissue regeneration in chronic and complex wounds.

Mesa, United StatesFounded 20181277K+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Chronic wounds often fail to heal due to persistent infection, inadequate tissue regeneration, and limited access to advanced dressings, leading to prolonged patient discomfort and higher healthcare costs.

Solution

BioLab creates clinically focused wound care products that combine synthetic antimicrobial matrices and biologically derived amniotic membranes to address the challenges of chronic wound healing. Their fully synthetic antimicrobial matrix provides a barrier against infection while supporting a moist healing environment. Hydrated dual‑layer amniotic membranes deliver native growth factors and extracellular matrix components to promote tissue regeneration. The triple‑layer amniotic wrap offers enhanced structural support and sustained release of bioactive molecules for deeper or more complex wounds. These therapies are manufactured under controlled conditions and distributed to healthcare providers and distributors worldwide, enabling clinicians to select evidence‑based options that improve healing outcomes.

Target Audience

Primary customers are wound care specialists, hospitals, and medical distributors that treat patients with chronic or complex wounds.

Features

  • Microlyte® SAM™: fully synthetic matrix with broad‑spectrum antimicrobial properties and high absorbency
  • Membrane Wrap
  • Hydro™: hydrated dual‑layer amniotic membrane preserving native growth factors for rapid epithelialization
  • Tri‑Membrane Wrap™: triple‑layer amniotic construct delivering extended structural support and sustained bioactive release
  • GMP‑compliant manufacturing process ensuring product consistency and safety
  • Compatibility with standard wound care protocols and easy integration into existing treatment regimens
This profile is AI-generated and may contain inaccuracies.